439 related articles for article (PubMed ID: 17915196)
1. Central administration of selective melanocortin 4 receptor antagonist HS014 prevents morphine tolerance and withdrawal hyperalgesia.
Kalange AS; Kokare DM; Singru PS; Upadhya MA; Chopde CT; Subhedar NK
Brain Res; 2007 Nov; 1181():10-20. PubMed ID: 17915196
[TBL] [Abstract][Full Text] [Related]
2. Involvement of neuropeptide Y in the acute, chronic and withdrawal responses of morphine in nociception in neuropathic rats: behavioral and neuroanatomical correlates.
Upadhya MA; Dandekar MP; Kokare DM; Singru PS; Subhedar NK
Neuropeptides; 2009 Aug; 43(4):303-14. PubMed ID: 19556004
[TBL] [Abstract][Full Text] [Related]
3. Involvement of alpha-melanocyte stimulating hormone (alpha-MSH) in differential ethanol exposure and withdrawal related depression in rat: neuroanatomical-behavioral correlates.
Kokare DM; Singru PS; Dandekar MP; Chopde CT; Subhedar NK
Brain Res; 2008 Jun; 1216():53-67. PubMed ID: 18499089
[TBL] [Abstract][Full Text] [Related]
4. Melanocortin 4 receptor antagonists attenuates morphine antinociceptive tolerance, astroglial activation and cytokines expression in the spinal cord of rat.
Niu Z; Ma J; Chu H; Zhao Y; Feng W; Cheng Y
Neurosci Lett; 2012 Nov; 529(2):112-7. PubMed ID: 23022502
[TBL] [Abstract][Full Text] [Related]
5. Lipoxin A4 analog attenuates morphine antinociceptive tolerance, withdrawal-induced hyperalgesia, and glial reaction and cytokine expression in the spinal cord of rat.
Jin H; Li YH; Xu JS; Guo GQ; Chen DL; Bo Y
Neuroscience; 2012 Apr; 208():1-10. PubMed ID: 22366510
[TBL] [Abstract][Full Text] [Related]
6. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
Dunbar SA; Karamian I; Zhang J
Eur J Pain; 2007 Jan; 11(1):1-6. PubMed ID: 16448827
[TBL] [Abstract][Full Text] [Related]
7. Participation of alpha-melanocyte stimulating hormone in ethanol-induced anxiolysis and withdrawal anxiety in rats.
Kokare DM; Chopde CT; Subhedar NK
Neuropharmacology; 2006 Sep; 51(3):536-45. PubMed ID: 16762375
[TBL] [Abstract][Full Text] [Related]
8. Morphine withdrawal modifies antinociceptive effects of acute morphine in rats.
Dong Z; Mao R; Han H; Cao J; Xu L
Biochem Biophys Res Commun; 2006 Jul; 346(2):578-82. PubMed ID: 16762316
[TBL] [Abstract][Full Text] [Related]
9. d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia.
Davis AM; Inturrisi CE
J Pharmacol Exp Ther; 1999 May; 289(2):1048-53. PubMed ID: 10215686
[TBL] [Abstract][Full Text] [Related]
10. Roles of the melanocortin-4 receptor in antipyretic and hyperthermic actions of centrally administered alpha-MSH.
Sinha PS; Schiöth HB; Tatro JB
Brain Res; 2004 Mar; 1001(1-2):150-8. PubMed ID: 14972664
[TBL] [Abstract][Full Text] [Related]
11. The intracerebroventricular (ICV) administration of W-7, a calmodulin inhibitor, attenuates the development of morphine tolerance in rats.
Sepehri G; Sheibani V; Azarang A; Shamsizadeh A; Afarinesh MR; Azizollahi S; Sepehri E
Pak J Pharm Sci; 2010 Apr; 23(2):170-4. PubMed ID: 20363694
[TBL] [Abstract][Full Text] [Related]
12. Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction.
Alvaro JD; Tatro JB; Quillan JM; Fogliano M; Eisenhard M; Lerner MR; Nestler EJ; Duman RS
Mol Pharmacol; 1996 Sep; 50(3):583-91. PubMed ID: 8794897
[TBL] [Abstract][Full Text] [Related]
13. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.
Juni A; Klein G; Kest B
Brain Res; 2006 Jan; 1070(1):35-44. PubMed ID: 16409995
[TBL] [Abstract][Full Text] [Related]
14. Is withdrawal hyperalgesia in morphine-dependent mice a direct effect of a low concentration of the residual drug?
Rubovitch V; Pick CG; Sarne Y
Addict Biol; 2009 Sep; 14(4):438-46. PubMed ID: 19489750
[TBL] [Abstract][Full Text] [Related]
15. Finasteride, a 5alpha-reductase inhibitor, potentiates antinociceptive effects of morphine, prevents the development of morphine tolerance and attenuates abstinence behavior in the rat.
Verdi J; Ahmadiani A
Horm Behav; 2007 May; 51(5):605-10. PubMed ID: 17428486
[TBL] [Abstract][Full Text] [Related]
16. Importance of sex and relative efficacy at the mu opioid receptor in the development of tolerance and cross-tolerance to the antinociceptive effects of opioids.
Barrett AC; Cook CD; Terner JM; Craft RM; Picker MJ
Psychopharmacology (Berl); 2001 Nov; 158(2):154-64. PubMed ID: 11702089
[TBL] [Abstract][Full Text] [Related]
17. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
Cavun S; Göktalay G; Millington WR
J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
[TBL] [Abstract][Full Text] [Related]
18. Anxiety-like behavior induced by IL-1beta is modulated by alpha-MSH through central melanocortin-4 receptors.
Cragnolini AB; Schiöth HB; Scimonelli TN
Peptides; 2006 Jun; 27(6):1451-6. PubMed ID: 16325304
[TBL] [Abstract][Full Text] [Related]
19. Central neuropeptide Y infusion and melanocortin 4 receptor antagonism inhibit thyrotropic function by divergent pathways.
Preston E; Cooney GJ; Wilks D; Baran K; Zhang L; Kraegen EW; Sainsbury A
Neuropeptides; 2011 Dec; 45(6):407-15. PubMed ID: 21862125
[TBL] [Abstract][Full Text] [Related]
20. HS014, a selective melanocortin-4 (MC4) receptor antagonist, modulates the behavioral effects of morphine in mice.
Ercil NE; Galici R; Kesterson RA
Psychopharmacology (Berl); 2005 Jul; 180(2):279-85. PubMed ID: 15719225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
